StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.56−0.04 (-7.07%)

Close on Nov 17, 2026Market cap $1.45MP/E –Yield –

Calidi Biotherapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Calidi Biotherapeutics's pe ratio was 659.5× on Apr 28, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 2023659.5×–

More Calidi Biotherapeutics figures

See a number that looks wrong?